BCI
EW icon

Brinker Capital Investments’s Edwards Lifesciences EW Stock Holding History

Brinker Capital Investments’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.28M Buy
25,234
+3,798
+18% +$318K 0.02% 724
2026
Q1 		$1.72M Buy
21,436
+6,882
+47% +$567K 0.01% 833
2025
Q4 		$1.24M Sell
14,554
-3,057
-17% -$251K 0.01% 1124
2025
Q3 		$1.37M Buy
17,611
+2,057
+13% +$161K 0.01% 1040
2025
Q2 		$1.22M Sell
15,554
-5,512
-26% -$411K 0.01% 1077
2025
Q1 		$1.53M Sell
21,066
-492
-2% -$35.2K 0.02% 858
2024
Q4 		$1.6M Sell
21,558
-8,974
-29% -$628K 0.02% 806
2024
Q3 		$2.01M Buy
+30,532
New +$2.22M 0.02% 685
2023
Q3 		– Sell
-42,298
Closed -$3.99M – 1632
2023
Q2 		$3.99M Sell
42,298
-6,433
-13% -$559K 0.04% 379
2023
Q1 		$4.03M Buy
48,731
+2,136
+5% +$168K 0.05% 324
2022
Q4 		$3.48M Buy
46,595
+4,036
+9% +$311K 0.07% 282
2022
Q3 		$3.52M Sell
42,559
-1,254
-3% -$121K 0.07% 268
2022
Q2 		$4.17M Sell
43,813
-3,075
-7% -$318K 0.08% 244
2022
Q1 		$5.52M Sell
46,888
-1,279
-3% -$143K 0.08% 233
2021
Q4 		$6.24M Sell
48,167
-888
-2% -$104K 0.09% 222
2021
Q3 		$5.08M Hold
49,055
– – 0.08% 257
2021
Q2 		$5.08M Buy
49,055
+1,232
+3% +$116K 0.07% 300
2021
Q1 		$4M Sell
47,823
-46,276
-49% -$3.91M 0.06% 306
2020
Q4 		$8.59M Buy
94,099
+44,081
+88% +$3.66M 0.13% 175
2020
Q3 		$3.99M Buy
+50,018
New +$3.9M 0.07% 286
2019
Q3 		– Sell
-1,548
Closed -$95K – 804
2019
Q2 		$95K Buy
1,548
+558
+56% +$33.7K ﹤0.01% 491
2019
Q1 		$63K Buy
+990
New +$56.5K ﹤0.01% 424
2018
Q3 		– Sell
-180
Closed -$9K – 648
2018
Q2 		$9K Buy
+180
New +$8.4K ﹤0.01% 497

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Brinker Capital Investments's EW Position: Q2 2026 in Review

Brinker Capital Investments increased its Edwards Lifesciences (EW) stake by 18% in Q2 2026, buying an estimated $318K and bringing the position to 25,234 shares worth $2.28M. The position accounts for 0.02% of the portfolio, ranked #724.

Brinker Capital Investments first reported a position in EW in Q2 2018 and has held it in 23 quarters since. The position peaked at $8.59M in Q4 2020. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Brinker Capital Investments held 25,234 shares of Edwards Lifesciences worth $2.28M as of Q2 2026.
  • Brinker Capital Investments bought 3,798 Edwards Lifesciences shares in Q2 2026, an estimated $318K.
  • Edwards Lifesciences made up 0.02% of Brinker Capital Investments's portfolio in Q2 2026, its #724 holding.
  • Brinker Capital Investments first reported a position in Edwards Lifesciences in Q2 2018 and has held it in 23 quarters since.
  • Brinker Capital Investments's Edwards Lifesciences position peaked at $8.59M in Q4 2020.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.